Who Is This Tool For?
Supporting Publication Visit PubMed for the journal article that supports this nomogram 
|
|
|
This tool can be used by patients and physicians to estimate their risk of experiencing a recurrence of disease after radical cystectomy for localized, locally advanced, or regionally advanced primary invasive bladder cancer. This includes individuals with transitional cell carcinoma (TCC) -- including TCC with elements of squamous cell carcinoma (SCC) or adenocarcinoma, -- SCC, or pure adenocarcinoma of the bladder. This tool is to be used for patients who have had radical cystectomy, including removal of the lymph nodes (pelvic lymphadenectomy), but NOT neoadjuvant or adjuvant chemotherapy or pelvic radiation. They may, however, have received intravesical therapy prior to surgery. This tool may be useful in determining the need for additional therapy after surgery. Patients should use this tool only in consultation with their physicians.
What Information Will You Need?
| Needed Information |
Parameters / Further Explanation |
| Gender |
Male or Female |
| Age |
Patient's age at the time of radical cystectomy |
| Number of days from diagnosis to radical cystectomy |
Must be between 0 and 1,000 |
| Stage |
According to the 1997 UICC clinical staging system: P0, PA, PIS, P1, P2, P3, P4 |
| Histology |
Type of bladder cancer diagnosed: transitional cell carcinoma (TCC), squamous cell carcinoma (SCC), or adenocarcinoma (ADENO) |
| Tumor Grade |
High or Low |
How to Access the Tool
To use the online version of this prediction tool, click here or on "open calculator" in the box at the top of the page. The calculator will open in a pop-up window.
Contact Us
If you have questions or comments, please do not hesitate to contact us at nomograms@mskcc.org.
